A detailed history of Merrion Investment Management Co, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Merrion Investment Management Co, LLC holds 2,200 shares of LLY stock, worth $2.01 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
2,200
Previous 2,200 -0.0%
Holding current value
$2.01 Million
Previous $1.28 Million 33.46%
% of portfolio
1.26%
Previous 1.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$321.55 - $374.67 $160,775 - $187,335
-500 Reduced 18.52%
2,200 $0
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $55,746 - $65,454
200 Added 8.0%
2,700 $875,000
Q4 2021

Feb 03, 2022

BUY
$224.85 - $279.04 $112,425 - $139,520
500 Added 25.0%
2,500 $690,000
Q2 2021

Jul 28, 2021

BUY
$180.55 - $233.54 $361,100 - $467,080
2,000 New
2,000 $459,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Merrion Investment Management Co, LLC Portfolio

Follow Merrion Investment Management Co, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merrion Investment Management Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merrion Investment Management Co, LLC with notifications on news.